Amylyx Pharmaceuticals Inc (AMLX)

Total Costs & Expenses

$45.69M

Quarterly · Period ending: · USD

AMLX logo

AMLX Total Costs & Expenses

Latest reported$45.69M
AMLX Quarterly Total Costs & Expenses ($8.59M → $45.69M)
High-resolution chart · PNG

AMLX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Amylyx Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
45,693,000
43,779,000
36,605,000
36,027,000
42,857,000
37,803,000
39,989,000
76,077,000
52,412,000
210,773,000
106,515,000
83,973,000
78,015,000
73,481,000
66,478,000
55,026,000
54,253,000
47,814,000
28,315,000
22,918,000
18,587,000
12,868,000
8,592,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.